Hanlan Liu, Ph.D., MBA

Hanlan is a biotech executive with over 20 years of experience in drug development, spanning small molecules to cell therapies. Her expertise covers oncology, immunology, and neurology, with a proven record of advancing programs to market and securing over $200M in venture funding. She holds an MBA from NYU Stern.

Outside of her corporate roles, Hanlan is deeply committed to patient advocacy for rare diseases. She is an active supporter of the Channeling Hope Foundation and participates in fundraising events, such as running half marathons, to support research and awareness for NALCN-associated diseases.

Unique fact: Hanlan connects her professional expertise with personal passion by running marathons to raise funds and awareness for rare disease research.